Cargando…

STAT5b in LGL leukemia – a novel therapeutic target?

Detalles Bibliográficos
Autores principales: Rajala, Hanna L. M., Mustjoki, Satu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757236/
https://www.ncbi.nlm.nih.gov/pubmed/23868875
_version_ 1782282178861727744
author Rajala, Hanna L. M.
Mustjoki, Satu
author_facet Rajala, Hanna L. M.
Mustjoki, Satu
author_sort Rajala, Hanna L. M.
collection PubMed
description
format Online
Article
Text
id pubmed-3757236
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-37572362013-09-03 STAT5b in LGL leukemia – a novel therapeutic target? Rajala, Hanna L. M. Mustjoki, Satu Oncotarget Editorial Impact Journals LLC 2013-05-16 /pmc/articles/PMC3757236/ /pubmed/23868875 Text en Copyright: © 2013 Rajala and Mustjoki http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
spellingShingle Editorial
Rajala, Hanna L. M.
Mustjoki, Satu
STAT5b in LGL leukemia – a novel therapeutic target?
title STAT5b in LGL leukemia – a novel therapeutic target?
title_full STAT5b in LGL leukemia – a novel therapeutic target?
title_fullStr STAT5b in LGL leukemia – a novel therapeutic target?
title_full_unstemmed STAT5b in LGL leukemia – a novel therapeutic target?
title_short STAT5b in LGL leukemia – a novel therapeutic target?
title_sort stat5b in lgl leukemia – a novel therapeutic target?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757236/
https://www.ncbi.nlm.nih.gov/pubmed/23868875
work_keys_str_mv AT rajalahannalm stat5binlglleukemiaanoveltherapeutictarget
AT mustjokisatu stat5binlglleukemiaanoveltherapeutictarget